Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed] ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 22nd, 2019 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations
This ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into by and between SONOMA PHARMACEUTICALS, inc., (previously known as Oculus Innovative sciEnces, INC.) a Corporation under the laws of Delaware hereinafter referred to as “Seller” and PETAGON LIMITED, an organization under the laws of Hong Kong, hereinafter referred to as “Buyer” (all Parties jointly referred to as the “Parties”) as of 14 May, 2019 (the “Effective Date”).
